Thrace Plastics Holding and Commercial S.A (PLAT)
Athens Stock Exchange · Greece · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 4.680 |
|---|---|
| 52-week range | 3.550 – 5.400 |
| Return, 1 month / 3 months | −7.3% / −0.4% |
| Return, 1 year / 3 years | +17.3% / +24.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 37 |
| Volatility (1 year) | 25.1% |
| Worst drawdown (1 year) | -19.1% |
| Average daily value traded | 0.19M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Thrace Plastics Holding and Commercial is a Greek industrial group that makes technical textiles and plastic products. It produces woven polypropylene fabrics, geotextiles and other synthetic textile materials, along with packaging such as large industrial bags and flexible films. Its customers are industrial and agricultural businesses and construction firms, and it supplies markets in Greece and abroad from production sites in Greece and other European countries.
Thrace Plastics Holding and Commercial S.A trades under the code PLAT on the Athens Stock Exchange in Greece, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Thrace Plastics Holding and Commercial S.A (PLAT) trades on the Athens Stock Exchange in Greece. It last closed at EUR 4.680 on 27 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 27 of 143 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 17.3% and over the last three months it fell 0.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Athens Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 70 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 4.9% | ||
| From 52-week high | -13.3% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -0.4% | ||
| 6-month return | 16.1% | ||
| 12-month return, skipping the last month | 26.6% | ||
| Stability (higher is calmer) | 73 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 25.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.1% | ||
| Liquidity | 66 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.19M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −2.5% |
|---|---|
| 1 month | −7.3% |
| 3 months | −0.4% |
| 6 months | +16.1% |
| 1 year | +17.3% |
| 3 years | +24.4% |
| 5 years | −21.5% |
Signals
| 50-day / 200-day average | 4.951 / 4.463 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.104 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 31 May 2023 | EUR 0.1931 |
| 30 Jan 2023 | EUR 0.0663 |
| 30 May 2022 | EUR 0.1625 |
| 1 Dec 2021 | EUR 0.1099 |
| 26 May 2021 | EUR 0.1600 |
| 17 Dec 2020 | EUR 0.0576 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Athens Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.